Search Results for "risperdal"
- Pa. appeals court sides with J&J
A state appeals court has upheld the dismissal of Pennsylvania’s lawsuit against Johnson & Johnson over allegations that the company improperly marketed its antipsychotic drug Risperdal, the Wall Street Journal reports. Pennsylvania prosecutors had filed suit against J&J in 2007, trying to...
- Johnson & Johnson reaches deal with prosecutors
The Wall Street Journal reports that Johnson & Johnson and federal prosecutors have reached a settlement over allegations that the company illegally marketed its antipsychotic drug Risperdal and other medications. That settlement will reportedly be about $2.2 billion, and include about $400 mill...
- Johnson & Johnson has history of ethical lapses
Johnson & Johnson will reportedly pay a settlement in the neighborhood of $2 billion to settle federal charges that the company used illegal tactics in marketing its antipsychotic drug Risperdal. The federal probe prompting that settlement included investigations into the company’s alleged kic...
- Critics doubt record settlement will be enough
The $3 billion fine recently leveled against GlaxoSmithKline is the largest settlement ever involving a pharmaceutical company. But in light of the enormous profits that the British pharmaceutical giant brings in, some critics wonder whether even that will be enough to dissuade companies from engagi...
- J&J hopes to avoid felony charge
According to a Wall Street Journal report, Johnson & Johnson and the U.S. Justice Department are close to settling a lengthy investigation into allegations that the company used illegal tactics in marketing its antipsychotic drug Risperdal. The report cites unnamed sources who said the settlemen...
- J&J reportedly plans $2.2 billion settlement
Bloomberg reports that Johnson & Johnson has agreed to pay as much as $2.2 billion to settle federal government investigations into claims that the company illegally marketed antipsychotic drug Risperdal and other medications. The report quotes unnamed sources as saying the settlement will inclu...
- Writer wonders if even Don Draper could help J&J
An entry on blog ThePopTort.com mentions Don Draper, the preternaturally slick ad executive at the center of AMC’s Mad Men, and wonders whether even he would be able to help Johnson & Johnson these days. “Last week watching Mad Men, when I heard Don Draper’s pitch to Dow Chemical about the...
- Lawyers give arguments in J&J fraud case
Lawyers representing Pennsylvania and Johnson & Johnson both argued their side before a panel of seven Commonwealth Court justices on Wednesday, in a case involving allegations that Johnson & Johnson defrauded Pennsylvania out of millions of taxpayer dollars. At issue is whether the company ...
- State court hears appeal in J&J fraud case
Commonwealth Court judges are scheduled to hear an appeal of the decision dismissing Pennsylvania’s 2008 lawsuit against Johnson & Johnson. The company is accused of fraudulently profiting from sales of the antipsychotic drug Risperdal through the Medicaid program. According to an article in t...
- NPR examines $1B Johnson & Johnson fine
An NPR report on an Arkansas jury’s billion-dollar decision against Johnson & Johnson mentions that the company is most famous for its baby shampoo and wryly notes: “So much for no more tears.” The federal court decision was in response to allegations that the company used misleading marke...
